Search PubMed⌕ Search

Biomedical subjects

E Lillehoj

Publications and source records attributed to E Lillehoj.

8 recordsLinked to original sources

Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia.

We employed enzyme immunoassay (EIA) and Western blotting techniques to measure the level of antibodies to Toxoplasma gondii proteins in serum samples from 38 individuals undergoing their first episode of schizophrenia and from a group of matched control subjects. We found that the individuals with first-episode schizophrenia had significantly increased levels of IgG, IgM, and IgA class antibodies to Toxoplasma proteins, as compared with the control subjects.

Adult↗

Examination of whether persistently indeterminate human immunodeficiency virus type 1 Western immunoblot reactions are due to serological reactivity with bovine immunodeficiency-like virus.

The bovine lentivirus, known as bovine immunodeficiency-like virus (BIV), is genetically, structurally, and antigenically related to human immunodeficiency virus type 1 (HIV-1). It is not known whether sera from persons exposed to BIV proteins would show either positive or indeterminate reactivity on HIV-1 antibody tests. We used a BIV Western blot (immunoblot) analysis to examine human sera characterized as HIV-1 antibody positive, HIV-1 antibody negative, HIV-1 persistently indeterminate, HIV-1 p17 antibody positive only, HIV-1 p24 antibody positive only, human T-cell leukemia virus type 1 (HTLV-1) p19 antibody positive only, or HTLV-1 p24 antibody positive only. None of these sera were positive by Western blot to BIV-specific proteins. Many of these sera, however, displayed strong reactivities to bovine cell culture antigens on blots prepared from both mock-infected and BIV-infected cell cultures. The HIV-1 p17 and p24 antibody-positive and the HTLV-1 p19 and p24 antibody-positive sera were further examined by Western blot to bovine leukemia virus (BLV) and were found to be negative. We examined sera from laboratory personnel at risk for BIV exposure, including two laboratory workers who were exposed to BIV by accidental injection with BIV-infected cell culture material, and found no evidence of seroconversion to BIV-specific proteins. We tested 371 samples of fetal bovine sera, each sample representing serum pooled from one to three fetuses. All samples were negative by BIV Western blot. To date, we have not detected any human sera with antibody to BIV-specific proteins. Our data indicate that persistently indeterminate results on HIV-1 Western blot are not caused by a human antibody response to BIV proteins.

Animals↗

Turkey beta 2-microglobulin--I. Isolation, properties and amino acid analysis.

Turkey beta 2-microglobulin (beta 2m) was purified from pooled serum by successive steps of ultrafiltration, gel filtration chromatography, lectin affinity chromatography, anion exchange chromatography, isoelectric focusing and a second step of gel filtration. Identification of turkey beta 2m was based upon NH2-terminal primary structure analysis. The NH2-terminal primary structure of turkey beta 2m is: NH2-Lys-Ile-Glu-Val-Tyr-Ile-Lys-. The purity of the isolated protein was confirmed by two-dimensional polyacrylamide gel electrophoresis, immunodiffusion and immunoelectrophoresis. Physicochemical parameters of turkey beta 2m are: mol. wt, 10,500 (observed), 9959 (calculated); beta electrophoretic mobility; pI, 4.7, 5.2; E1%280, 10.9; absence of terminal D-mannopyranosyl and D-glucopyranosyl residues. Amino acid composition analysis demonstrated similarities between turkey and chicken beta 2ms that distinguished them from mammalian beta 2ms.

Amino Acid Sequence↗

Turkey beta 2-microglobulin--II. Physiological parameters investigated by radioimmunoassay.

A competitive binding radioimmunoassay (RIA) was developed utilizing 125I-labeled turkey beta 2-microglobulin (beta 2m), rabbit anti-turkey beta 2m serum and polyethylene glycol for separation of bound and free antigen. The antibody-antigen reaction was demonstrated to be monospecific by immunofixation electrophoresis. Characteristic parameters of the RIA were: nonspecific binding, 5.5%; linear dose-response range, 0.24-64.0 ng turkey beta 2m; dose-response correlation coefficient, -0.995; assay sensitivity, 0.52 ng; upper limit of precision, 40.4 ng. RIA analysis of adult turkey tissue and organ homogenates revealed highest amounts (greater than 10 micrograms turkey beta 2m/g) in liver and kidney and intermediate levels (2-10 micrograms/g) in lymphoid organ (thymus, spleen, caecal tonsil, bursa), skin and lung extracts. Erythrocytes and peripheral blood lymphocyte extracts contained 8.0 and 5.1 micrograms/10(9) cells respectively whereas all other tissues examined expressed greater than 2.0 micrograms/g. The beta 2m content in turkey serum was 192.5 micrograms/ml. The molecular weight distribution of turkey beta 2m in serum determined by gel permeation chromatography consisted of a minor component of approximately 60,000 daltons and a major fraction eluting at a position characteristic of free beta 2m. A cross-reaction between turkey and mammalian beta 2ms was not observed.

Animals↗